L303-3196 Screening compound: 1-{4-[5-(2H-1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-3-yl]benzenesulfonyl}-4-(pyrrolidine-1-carbonyl)piperidine

L303-3196 Screening compound: 1-{4-[5-(2H-1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-3-yl]benzenesulfonyl}-4-(pyrrolidine-1-carbonyl)piperidine
L303-3196 Screening compound: 1-{4-[5-(2H-1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-3-yl]benzenesulfonyl}-4-(pyrrolidine-1-carbonyl)piperidine alternative view

Chemical Structure Depiction of ChemDiv screening compound L303-3196
1-{4-[5-(2H-1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-3-yl]benzenesulfonyl}-4-(pyrrolidine-1-carbonyl)piperidine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L303-3196

Molecular Formula

C25H26N4O6S (C25 H26 N4 O6 S)

Compound Name

1-{4-[5-(2H-1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-3-yl]benzenesulfonyl}-4-(pyrrolidine-1-carbonyl)piperidine

IUPAC name

1-{4-[5-(2H-13-benzodioxol-5-yl)-124-oxadiazol-3-yl]benzenesulfonyl}-4-(pyrrolidine-1-carbonyl)piperidine

SMILES

O=C(C(CC1)CCN1S(c(cc1)ccc1-c1noc(-c(cc2)cc3c2OCO3)n1)(=O)=O)N1CCCC1

InChI

InChI=1S/C25H26N4O6S/c30-25(28-11-1-2-12-28)18-9-13-29(14-10-18)36(31,32)20-6-3-17(4-7-20)23-26-24(35-27-23)19-5-8-21-22(15-19)34-16-33-21/h3-8,15,18H,1-2,9-14,16H2

InChI Key

FSCPUGHDSVTFFG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27243090

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

510.57

Hydrogen Bond Acceptors Count

12.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.997

Distribution Coefficient, logD

3.997

Water Solubility, LogSw

-4.20

Polar Surface Area

97.485

Acid Dissociation Constant (pKa)

23.63

Base Dissociation Constant (pKb)

-1.28

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.00

L303-3196 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular

References: we are preparing a list of scientific research reports with L303-3196 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L303-3196?
Check Price and Availability of L303-3196, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L303-3196 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L303-3196
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L303-3196
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L303-3196 available by request